Literature DB >> 30269233

Engagement in Maximally-Assisted Therapy and Adherence to Antiretroviral Therapy Among a Cohort of Indigenous People Who Use Illicit Drugs.

Brittany Barker1,2, Evan Adams3, Evan Wood1,4, Thomas Kerr1,4, Kora DeBeck1,5, Huiru Dong1,6, Jean Shoveller6, Julio Montaner7, M-J Milloy8,9.   

Abstract

Throughout the world, Indigenous populations experience a disproportionate burden of HIV infection. Maximally-assisted therapy (MAT) is an interdisciplinary care intervention that includes ART dispensation to support individuals with a history of addiction and homelessness. This study sought to longitudinally evaluate the relationship between engagement in MAT and achieving optimal adherence using data from an ongoing cohort of HIV-positive individuals who use drugs in Vancouver, Canada, where HIV/AIDS treatment is offered at no cost. Between December 2005 and November 2016, 354 HIV-positive Indigenous participants were enrolled and data were analyzed using generalized mixed-effects (GLMM) and marginal structural modeling. In both multivariable analyses, engagement in MAT was independently associated with optimal adherence to ART (GLMM: AOR = 4.92, 95% CI 3.18-7.62; marginal structural model: AOR = 5.76, 95% CI 3.34-9.96). MAT-based programmes could be a part of a renewed evidence-base to elevated levels of preventable HIV/AIDS-associated morbidity, mortality and viral transmission among Indigenous peoples in Canada.

Entities:  

Keywords:  Antiretroviral therapy; Canada; HIV; HIV interventions; Indigenous people; People who use drugs

Mesh:

Substances:

Year:  2019        PMID: 30269233      PMCID: PMC6440861          DOI: 10.1007/s10461-018-2226-y

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  34 in total

1.  Adherence to triple therapy and viral load response.

Authors:  S Low-Beer; B Yip; M V O'Shaughnessy; R S Hogg; J S Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2000-04-01       Impact factor: 3.731

2.  Directly observed therapy to treat HIV infection in prisoners.

Authors:  S Babudieri; A Aceti; G P D'Offizi; S Carbonara; G Starnini
Journal:  JAMA       Date:  2000-07-12       Impact factor: 56.272

3.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

4.  Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.

Authors:  Miguel A Hernán; Babette A Brumback; James M Robins
Journal:  Stat Med       Date:  2002-06-30       Impact factor: 2.373

5.  A structural approach to selection bias.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz; James M Robins
Journal:  Epidemiology       Date:  2004-09       Impact factor: 4.822

6.  The use of community-based modified directly observed therapy for the treatment of HIV-infected persons.

Authors:  Jennifer A Mitty; Grace E Macalino; Lauri B Bazerman; Helen G Loewenthal; Joseph W Hogan; Cynthia J MacLeod; Timothy P Flanigan
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-15       Impact factor: 3.731

7.  Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users.

Authors:  Evan Wood; Thomas Kerr; Anita Palepu; Ruth Zhang; Steffanie A Strathdee; Mark W Tyndall; Julio S G Montaner; Robert S Hogg
Journal:  J Infect       Date:  2005-09-19       Impact factor: 6.072

8.  Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.

Authors:  Gregory M Lucas; B Anna Mullen; Paul J Weidle; Shannon Hader; Mary E McCaul; Richard D Moore
Journal:  Clin Infect Dis       Date:  2006-04-28       Impact factor: 9.079

9.  Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy.

Authors:  Evan Wood; Julio S G Montaner; Mark W Tyndall; Martin T Schechter; Michael V O'Shaughnessy; Robert S Hogg
Journal:  J Infect Dis       Date:  2003-10-01       Impact factor: 5.226

10.  Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.

Authors:  Evan Wood; Robert S Hogg; Benita Yip; P Richard Harrigan; Michael V O'Shaughnessy; Julio S G Montaner
Journal:  Ann Intern Med       Date:  2003-11-18       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.